For The Cancer Genome Atlas (TCGA) dataset, we used the curated dataset by Nicolle et al. [54] to separate samples into nontumor (i.e., normal pancreas, atrophic pancreas or noninvasive intraductal papillary mucinous neoplasms), neuroendocrine tumors (NET), or PDAC, and again observed higher levels of SRC in PDAC versus nontumor samples (Figure 1B). The gene discussed is SRC; the disease is neuroendocrine neoplasm.